Cero Therapeutics Insider Trading Update
Ticker: CERO · Form: 4 · Filed: Apr 21, 2026 · CIK: 0001870404
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
CERO insider Eric Francois filed a Form 4 on ownership changes.
AI Summary
On March 4, 2026, Eric Francois reported a change in beneficial ownership of securities for CERO THERAPEUTICS HOLDINGS, INC. The filing details transactions related to his holdings, but specific dollar amounts and the exact nature of the transactions are not provided in this excerpt.
Why It Matters
Insider transactions can signal management's confidence in the company's future prospects. Investors often monitor these filings for potential investment insights.
Risk Assessment
Risk Level: low — Form 4 filings report changes in beneficial ownership, which are routine disclosures and do not inherently indicate high risk.
Key Players & Entities
- Eric Francois (person) — Reporting Person
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Issuer
- 0001870404 (company) — Issuer CIK
- 0001213900-26-046329 (filing_id) — SEC Accession Number
FAQ
What type of filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
Who is the reporting person?
The reporting person is Eric Francois.
What company is this filing related to?
The filing is related to CERO THERAPEUTICS HOLDINGS, INC.
When was the period of report for this filing?
The period of report was March 4, 2026.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001213900-26-046329.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 21, 2026 by Eric Francois regarding CERO THERAPEUTICS HOLDINGS, INC. (CERO). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.